Skip Nav Destination
Issues
Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
Ruiliang Wang; Qiufan Xu; Hanxu Guo; Guanjie Yang; Jun Zhang; Hong Wang; Tianyuan Xu; Changcheng Guo; Jing Yuan; Yanyan He; Xiaoying Zhang; Hongliang Fu; Guang Xu; Binghui Zhao; Jun Xie; Tingting Zhao; Longfei Huang; Jiansheng Zhang; Bo Peng; Xudong Yao; Bin Yang
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies
Jack Carter; Michael Hulse; Monisha Sivakumar; Jessica Burtell; Venkat Thodima; Min Wang; Anjana Agarwal; Komali Vykuntam; Jacob Spruance; Neha Bhagwat; Joseph Rager; Bruce Ruggeri; Peggy Scherle; Koichi Ito
Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients
Wei Tang; Flora Zhang; Jung S. Byun; Tiffany H. Dorsey; Harris G. Yfantis; Anuoluwapo Ajao; Huaitian Liu; Margaret S. Pichardo; Catherine M. Pichardo; Alexandra R. Harris; Xiaohong R. Yang; Jonine D. Figueroa; Shahin Sayed; Francis W. Makokha; Stefan Ambs
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans
Alexandra V. Vylegzhanina; Ivan A. Bespalov; Ksenia A. Novototskaya-Vlasova; Brandon M. Hall; Anatoli S. Gleiberman; Han Yu; Olga V. Leontieva; Katerina I. Leonova; Oleg V. Kurnasov; Andrei L. Osterman; Grace K. Dy; Alexey A. Komissarov; Elena Vasilieva; Jeff Gehlhausen; Akiko Iwasaki; Christine B. Ambrosone; Takemasa Tsuji; Junko Matsuzaki; Kunle Odunsi; Ekaterina L. Andrianova; Andrei V. Gudkov
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription
Melanie M. Frigault; Arushi Mithal; Harvey Wong; Beatrix Stelte-Ludwig; Vinay Mandava; Xin Huang; Joseph Birkett; Amy J. Johnson; Raquel Izumi; Ahmed Hamdy
Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
Henriette C. Jodal; Eddymurphy U. Akwiwu; Margriet Lemmens; Pien M. Delis-van Diemen; Dagmar Klotz; Leticia G. Leon; Soufyan Lakbir; Meike de Wit; Remond J.A. Fijneman; Monique E. van Leerdam; Evelien Dekker; Manon C.W. Spaander; Gerrit A. Meijer; Magnus Løberg; Veerle M.H. Coupé; Mette Kalager; Beatriz Carvalho
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez; Bryan Fisk; Joshua F. McMichael; Matthew Mosior; Jennifer A. Foltz; Zachary L. Skidmore; Eric J. Duncavage; Christopher A. Miller; Haley Abel; Yi-Shan Li; David A. Russler-Germain; Kilannin Krysiak; Marcus P. Watkins; Cody A. Ramirez; Alina Schmidt; Fernanda Martins Rodrigues; Lee Trani; Ajay Khanna; Julia A. Wagner; Robert S. Fulton; Catrina C. Fronick; Michelle D. O'Laughlin; Timothy Schappe; Amanda F. Cashen; Neha Mehta-Shah; Brad S. Kahl; Jason Walker; Nancy L. Bartlett; Malachi Griffith; Todd A. Fehniger; Obi L. Griffith
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer
Yu-Chen Cheng; Shayna Stein; Agostina Nardone; Weihan Liu; Wen Ma; Gabriella Cohen; Cristina Guarducci; Thomas O. McDonald; Rinath Jeselsohn; Franziska Michor
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Ailin Zhang; Nathan A. Lau; Alicia Wong; Lisha G. Brown; Ilsa M. Coleman; Navonil De Sarkar; Dapei Li; Diana C. DeLucia; Mark P. Labrecque; Holly M. Nguyen; Jennifer L. Conner; Ruth F. Dumpit; Lawrence D. True; Daniel W. Lin; Eva Corey; Joshi J. Alumkal; Peter S. Nelson; Colm Morrissey; John K. Lee
Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk Neuroblastoma
Zhang'E Choo; Xiaoying Koh; Megan Rui En Wong; Ruth Minothini Ashokan; Nurul Suhana Binte Ali Ahamed; CongBao Kang; Chik Hong Kuick; Kenneth Tou En Chang; Sarit Larisch; Amos Hong Pheng Loh; Zhi Xiong Chen
Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation
Emma Guyonnet; Shana J. Kim; Yue Yin Xia; Vasily Giannakeas; Jan Lubinski; Susan Randall Armel; Andrea Eisen; Louise Bordeleau; Charis Eng; Olufunmilayo I. Olopade; Nadine Tung; William D. Foulkes; Fergus J. Couch; Amber M. Aeilts; Steven A. Narod; Joanne Kotsopoulos
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds